Publication | Open Access
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
116
Citations
29
References
2019
Year
UrologyGenitourinary CancerMedicineNivolumab-ipilimumab FailurePharmacologyImmune Checkpoint InhibitorPharmacotherapyTumor TargetingCancer TreatmentOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1